Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc. (PCRX) is a publicly traded company in the Unknown sector. Across all available filings, 54 corporate insiders have executed 1022 transactions totaling $459.4M, demonstrating a bearish sentiment with -$412.8M in net insider flow. The most recent transaction on Feb 2, 2026 involved a sale of 13,137 shares valued at $269.7K.
PCRX Insider Activity Summary
Who Is Buying PCRX Stock?
No significant insider buying has been recorded for PCRX in the recent period.
Who Is Selling PCRX Stock?
No significant insider selling has been recorded for PCRX in the recent period.
Is Pacira Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PCRX is bearish with an Insider Alignment Score of 5/100 and a net flow of -$412.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PCRX Frequently Asked Questions
Understanding PCRX Insider Activity
Insider trading at Pacira Pharmaceuticals, Inc. (PCRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 54 insiders are actively trading PCRX stock, having executed 1022 transactions in the past 90 days. The most active insider is Andreas Wicki (Executive), who has made 82 transactions totaling $149.2M.
Related Tools
Track Pacira Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at PCRX file new Form 4 transactions